AstraZeneca PLC AZN-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 12/06/21 GMT
8,363.00UNCH (UNCH)
52 week range
6,499.80 - 9,523.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8,363.00
  • 52 Week High9,523.00
  • 52 Week High Date11/05/21
  • 52 Week Low6,499.80
  • 52 Week Low Date05/21/21

Key Stats

  • Market Cap167,843.38M
  • Shares Out1,549.14M
  • 10 Day Average Volume2.03M
  • Dividend202.20
  • Dividend Yield2.42%
  • Beta0.17
  • YTD % Change14.19

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8,363.00
  • 52 Week High9,523.00
  • 52 Week High Date11/05/21
  • 52 Week Low6,499.80
  • 52 Week Low Date05/21/21
  • Market Cap167,843.38M
  • Shares Out1,549.14M
  • 10 Day Average Volume2.03M
  • Dividend202.20
  • Dividend Yield2.42%
  • Beta0.17
  • YTD % Change14.19

RATIOS/PROFITABILITY

  • EPS (TTM)95.11
  • P/E (TTM)87.93
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/12/2021
  • Div Amount64.80
  • Split Date-
  • Split Factor-

Related Video

VIDEO3:0603:06
What worked today: PFE up even as MRNA sinks

Profile

MORE
AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of...
Leif Johansson
Non-Executive Chairman
Pascal Soriot
Chief Executive Officer
Aradhana Sarin M.D.
Chief Financial Officer
Ruud Dobber Ph.D.
Executive Vice President
Menelas Pangalos
Executive Vice President
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom